Lee’s Pharmaceutical Announces First Patient Dosed With its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, as a First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement